SPDR S&P Biotech ETF (NYSEARCA:XBI – Get Free Report)’s stock price reached a new 52-week low on Monday . The company traded as low as $79.32 and last traded at $80.57, with a volume of 3878634 shares changing hands. The stock had previously closed at $84.40.
SPDR S&P Biotech ETF Stock Performance
The firm has a fifty day moving average price of $89.40 and a 200-day moving average price of $93.91. The company has a market capitalization of $5.20 billion, a price-to-earnings ratio of 11.47 and a beta of 0.99.
SPDR S&P Biotech ETF Cuts Dividend
The company also recently announced a dividend, which was paid on Wednesday, March 26th. Stockholders of record on Monday, March 24th were given a $0.0053 dividend. The ex-dividend date of this dividend was Monday, March 24th.
Institutional Investors Weigh In On SPDR S&P Biotech ETF
About SPDR S&P Biotech ETF
SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.
Further Reading
- Five stocks we like better than SPDR S&P Biotech ETF
- 3 Fintech Stocks With Good 2021 Prospects
- 3 Stocks Near 52-Week Lows With Strong Rebound Potential
- Where to Find Earnings Call Transcripts
- Casey’s General Stores Insider Buys Shares of This Must-Own Stock
- Using the MarketBeat Stock Split Calculator
- U.S. Steel and Nippon Merger: Should Investors Bet on It?
Receive News & Ratings for SPDR S&P Biotech ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SPDR S&P Biotech ETF and related companies with MarketBeat.com's FREE daily email newsletter.